Organizational structure

Headed by the institute director, Fraunhofer ITEM is organized in six divisions. The institute‘s headquarters with most of its divisions are in Hannover (Germany), except for the Division of Pharmaceutical Biotechnology, which has its facilities in Braunschweig on the Science Campus Braunschweig-Süd, and the Division of Personalized Tumor Therapy, which is based in Regensburg‘s BioPark. The Fraunhofer ITEM Division of Personalized Tumor Therapy was set up as a joint initiative of Fraunhofer ITEM, the Fraunhofer-Gesellschaft, and the University of Regensburg.

Facts and figures

At the end of 2018, 357 people were employed at Fraunhofer ITEM. The institute's sponsors include industry and commercial associations, the public sector, and the EU. The institute's budget in 2018 reached a level of 28,9 million euros. For more details, please click on the below figures (as of April 2019).

Diagram of Fraunhofer ITEM total headcount in the years 2015 to 2018 — © Fraunhofer ITEM
Overview of Fraunhofer ITEM total headcount in the years 2015 to 2018

Diagram of Fraunhofer ITEM total budget in the years 2015 to 2018 — © Fraunhofer ITEM
Overview of Fraunhofer ITEM total budget in the years 2015 to 2018

Diagram of Fraunhofer ITEM external income in the years 2015 to 2018 — © Fraunhofer ITEM
Overview of Fraunhofer ITEM external income in the years 2015 to 2018

Would you like to learn more about Fraunhofer ITEM?

Annual report

The latest Fraunhofer ITEM Annual Report provides comprehensive information about the institute and recent research projects.

more info

Institute chronicles

Please click below to learn more about the history of Fraunhofer ITEM since 1981.

MORE INFO

About the Fraunhofer-Gesellschaft

The Fraunhofer-Gesellschaft is the leading organization for applied research in Europe. Its research activities are conducted by 72 institutes and research units at locations throughout Germany. The Fraunhofer-Gesellschaft employs a staff of more than 26,600, who work with an annual research budget totaling 2.6 billion euros. Of this sum, 2.2 billion euros is generated through contract research. Around 70 percent of the Fraunhofer-Gesellschaft’s contract research revenue is derived from contracts with industry and from publicly financed research projects. International collaborations with excellent research partners and innovative companies around the world ensure direct access to regions of the greatest importance to present and future scientific progress and economic development.

Fraunhofer Institute for Toxicology and Experimental Medicine

Profile of Fraunhofer ITEM